Langsung ke konten

Thalasemia Beta Mayor

Risiko dan Ketidakpastian Transfusi

Seropositivity of hepatitis C, hepatitis B and HIV in chronically transfused β-thalassaemia major patients. (terbuka di window baru)

Ansari SH, Shamsi TS, Khan MT, Perveen K, Farzana T, Erum S, Ansari I.

Sumber‎: J Coll Physicians Surg Pak 2012;22(9):610-1.

Index‎: PubMed 22980623

DOI‎: 09.2012/JCPSP.610611

https://www.ncbi.nlm.nih.gov/pubmed/22980623 (terbuka di window baru)

Clinical outcome of frequent exposure to Torque Teno virus (TTV) through blood transfusion in thalassemia patients with or without hepatitis C virus (HCV) infection. (terbuka di window baru)

Hu YW, Al-Moslih MI, Al Ali MT, Uzicanin S, Perkins H, Yi QL, Rahimi Khameneh S, Wu J, Brown EG.

Sumber‎: J Med Virol 2008;80(2):365-71.

Index‎: PubMed 18098140

DOI‎: 10.1002/jmv.21070

https://www.ncbi.nlm.nih.gov/pubmed/18098140 (terbuka di window baru)

Prevalence of alloimmunisation in patients with beta thalassaemia major. (terbuka di window baru)

Kosaryan M, Mahdavi MR, Roshan P, Hojjati MT.

Sumber‎: Blood Transfus 2012;10(3):396-7.

Index‎: PubMed 22395351

DOI‎: 10.2450/2012.0072-11

https://www.ncbi.nlm.nih.gov/pubmed/22395351 (terbuka di window baru)

Marseillevirus prevalence in multitransfused patients suggests blood transmission. (terbuka di window baru)

Popgeorgiev N, Colson P, Thuret I, Chiarioni J, Gallian P, Raoult D, Desnues C.

Sumber‎: J Clin Virol 2013;58(4):722-5.

Index‎: PubMed 24183312

DOI‎: 10.1016/j.jcv.2013.10.001

https://www.ncbi.nlm.nih.gov/pubmed/24183312 (terbuka di window baru)